Authors: CHAPMAN MS ZUG KA LEWIS LD

Citation: Ms. Chapman et al., LAMOTRIGINE AND PHENOBARBITONE-ASSOCIATED HYPERSENSITIVITY SYNDROME -RESOLUTION WITHOUT CORTICOSTEROIDS, British journal of dermatology, 138(4), 1998, pp. 710-711

Authors: CAMPBELL JL ZUG KA

Citation: Jl. Campbell et Ka. Zug, LONG-TERM LOW-DOSE CYCLOSPORINE THERAPY FOR PSORIASIS, Journal of the American Academy of Dermatology, 37(4), 1997, pp. 671-671

Authors: ZUG KA

Citation: Ka. Zug, ECZEMATOUS DERMATITIS - A PRACTICAL REVIEW (VOL 54, PG 1243, 1996), American family physician, 55(2), 1997, pp. 448-448

Authors: ZUG KA PALAY DA ROCK B

Citation: Ka. Zug et al., DERMATOLOGICAL DIAGNOSIS AND TREATMENT OF ITCHY RED EYELIDS, Survey of ophthalmology, 40(4), 1996, pp. 293-306

Authors: ZUG KA MCKAY M

Citation: Ka. Zug et M. Mckay, ECZEMATOUS DERMATITIS - A PRACTICAL REVIEW, American family physician, 54(4), 1996, pp. 1243-1250

Authors: ZUG KA LITTENBERG B BAUGHMAN RD KNEELAND T NEASE RF SUMNER W OCONNOR GT JONES R MORRISON E CIMIS R

Citation: Ka. Zug et al., ASSESSING THE PREFERENCES OF PATIENTS WITH PSORIASIS - A QUANTITATIVE, UTILITY APPROACH, Archives of dermatology, 131(5), 1995, pp. 561-568